# NTUT develops portable lab-on-a-chip to detect heart biomarkers in 10 minutes

- Published: 2026-11-08 00:30 UTC
- Section: Life & Health › Medicine
- Tags: National Taipei University of Technology, portable lab on a chip, cardiac troponin I, creatine kinase-MB, B-type natriuretic peptide, cardiovascular diagnostics, point of care testing
- URL: https://realtech.media/news/rt-1b85512120afcce0d9cf3dd5_ntut_develops_portable/

**Engineers from Taiwan created a prototype test system that requires 10 microliters of blood to measure three cardiac indicators.**

![NTUT develops portable lab-on-a-chip to detect heart biomarkers in 10 minutes](https://realtech.media/media/2026/11/fc89f33f06f341b1.webp)
*ua.news*

A development team from the National Taipei University of Technology (NTUT) presented a portable diagnostic platform capable of detecting cardiovascular biomarkers within 10 minutes, according to ua.news [1]. The project received an Honorable Mention and a 10,000 USD prize in the Healthy Longevity Global Competition organized by the US National Academy of Medicine [1]. The initiative concluded a seven-year international cycle, leaving the NTUT team as the only honored group from Taiwan [1].

## Technical characteristics

The portable lab-on-a-chip system requires 10 microliters of blood to detect three clinical markers: cardiac troponin I, creatine kinase-MB, and B-type natriuretic peptide [1]. According to the developers, the production cost of the testing device remains below 10 USD, while analytical sensitivity reaches under 1 picogram per milliliter [1]. The engineering architecture combines magnetic nanoparticles with aptamer structures optimized for specific target binding [1]. The manufacturing process achieves a defect rate of 1.8%, as reported by the development group [1].

## Validation stages

The engineering group collaborates with Mackay Memorial Hospital to verify device performance on biological samples [1]. An application for approval to conduct human trials is currently under regulatory review, meaning formal clinical investigation has not started [1]. Once clearance is granted, the researchers intend to conduct clinical validation, fulfill regulatory requirements, and prepare industrial fabrication [1]. The planned roadmap includes integrating the diagnostic chip with smartphones for decentralized screening in remote regions [1].

## Sources

1. [ua.news](https://ua.news/en/dovkolo-svitu/komanda-ntut-zdobula-nagorodu-za-portativnii-sertsevii-chip-taipei-times)

---

Source: RealTech, realtech.media — https://realtech.media/news/rt-1b85512120afcce0d9cf3dd5_ntut_develops_portable/